內分泌病理學 SCIE

期刊簡介預計審稿時間： 12周，或約稿

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.

《內分泌病理學》發表關于內分泌疾病臨床和基礎方面的原創文章。如果與人類正常或異常內分泌學相關，則可接受動物或體外技術研究。稿件將以原創文章、病例報告、臨床病例陳述、評論和技術描述的形式考慮發表。提交論文意味著它報告了未發表的作品（摘要形式除外），并且不會同時提交給其他出版物。接受的稿件將成為《內分泌病理學》的唯一財產，未經出版商書面同意不得在其他地方發表。所有文章均需經過經驗豐富的審稿人的審查。編輯和編輯委員會判斷稿件是否適合發表，編輯的決定為最終決定。

《Endocrine Pathology》(內分泌病理學)編輯部通訊方式為HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。